John Ernest Nosenzo
Net Worth
Last updated:
What is John Ernest Nosenzo net worth?
The estimated net worth of Mr. John Ernest Nosenzo is at least $4,983,412 as of 4 Apr 2022. He owns shares worth $614,382 as insider, has earned $739,910 from insider trading and has received compensation worth at least $3,629,120 in Bioventus Inc..
What is the salary of John Ernest Nosenzo?
Mr. John Ernest Nosenzo salary is $907,280 per year as Senior Vice President & Chief Commercial Officer in Bioventus Inc..
How old is John Ernest Nosenzo?
Mr. John Ernest Nosenzo is 67 years old, born in 1958.
What stocks does John Ernest Nosenzo currently own?
As insider, Mr. John Ernest Nosenzo owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Bioventus Inc. (BVS) | Senior Vice President & Chief Commercial Officer | 83,932 | $7.32 | $614,382 |
What does Bioventus Inc. do?
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
John Ernest Nosenzo insider trading
Bioventus Inc.
Mr. John Ernest Nosenzo has made 2 insider trades between 2021-2022, according to the Form 4 filled with the SEC. Most recently he sold 65,963 units of BVS stock worth $733,509 on 4 Apr 2022.
The largest trade he's ever made was exercising 106,485 units of BVS stock on 1 Apr 2022. As of 4 Apr 2022 he still owns at least 83,932 units of BVS stock.
Bioventus key executives
Bioventus Inc. executives and other stock owners filed with the SEC:
- Mr. Anthony D'Adamio (64) Senior Vice President, Gen. Counsel & Corporation Sec.
- Mr. Gregory O. Anglum (54) Senior Vice President, Chief Financial Officer & Principal Accounting Officer
- Mr. John Ernest Nosenzo (67) Senior Vice President & Chief Commercial Officer
- Mr. Kenneth M. Reali (59) Chief Executive Officer & Director
- Ms. Alessandraa Pavesio (58) Senior Vice President & Chief Science Officer